GDTC - CytoMed Therapeutics Ltd

GDTC is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.

Is anyone targeting this fund?

Yes - 2 large investors hold stakes in this company, and 1 of them is pushing for changes.

What this means for you

Choo Chee Kong has told the regulator it may push for changes at this company. That usually means asking for a seat on the board, a sale of the company, or a change in how it is run.

Nothing is required of you now.

Large investors can also sell down and walk away. We show every notice they file, the day it is filed.

Email me if this changes

What happened, and when

  1. Oct 23, 2026

    mDR LTD now owns 10%, as a passive investor.

    Original document →
  2. Oct 16, 2026

    Choo Chee Kong raised its stake to 25.2% (from 24.9%). It has said it may push for changes.

    Original document →
  3. Oct 13, 2026

    Choo Chee Kong now owns 24.9%. It has said it may push for changes.

    Original document →
Details: all notices, events and fund facts
Notices from large investors about GDTC
DateInvestorStakeType of notice
Oct 23, 2026 mDR LTD 10% Updated notice
Oct 16, 2026 Choo Chee Kong 25.2% Updated notice
Oct 13, 2026 Choo Chee Kong 24.9% Updated notice

No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.

Run by
not filed yet
Fund family
not filed yet
Exchange
Nasdaq

See this fund's page at the SEC →

Download this fund's history (CSV)

Follow this fund in a news reader (feed)

Email me when something new is filed for GDTC

Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.